RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com
  

Medimmune Limited patents

Recent patent applications related to Medimmune Limited. Medimmune Limited is listed as an Agent/Assignee. Note: Medimmune Limited may have other listings under different names/spellings. We're not affiliated with Medimmune Limited, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Medimmune Limited-related inventors




Date Medimmune Limited patents (updated weekly) - BOOKMARK this page
06/22/17 new patent  Stabilized angiopoietin-2 antibodies and uses thereof
06/15/17Ion channel modulators and uses thereof
05/25/17Targeted pyrrolobenzodiazapine conjugates
05/18/17Targeted binding agents against b7-h1
04/27/17Multispecific and multivalent binding proteins and uses thereof
04/13/17Human anti il-6 antibodies with extended in vivo half-life and their use in treatment of oncology, autoimmune diseases and inflammatory diseases
03/16/17Gitrl fusion proteins and uses thereof
02/02/17Methods for treating hepcidin-mediated disorders
02/02/17Anti-siglec-15 antibodies and uses thereof
12/22/16Anti-pcsk9-glp-1 fusions and methods for use
12/01/16Therapeutic combinations and methods for treating neoplasia
11/03/16Protease resistant peptides
11/03/16Methods of treating and diagnosing alpha-v-beta-6 overexpressing cancer
10/27/16Peptidomimetic compounds and antibody-drug conjugates thereof
10/13/16Specific binding members for ngf
10/06/16Pyrrolobenzodiazepines and targeted conjugates
10/06/16Pyrrolobenzodiazepines and targeted conjugates
09/29/16Human antibody molecules for il-13
09/22/16Il-13 binding proteins and uses thereof
09/15/16Pyrrolobenzodiazepine-antibody conjugates
09/15/16Pyrrolobenzodiazepine-antibody conjugates
09/08/16Pyrrolobenzodiazepine-antibody conjugates
09/08/16Human antibodies against eotaxin and their use
09/01/16Pyrrolobenzodiazepines and conjugates thereof
09/01/16Pyrrolobenzodiazepines and conjugates thereof
09/01/16Pyrrolobenzodiazepine-antibody conjugates
09/01/16Rsv-specific binding molecule
09/01/16Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancer
08/25/16Rsv-specific binding molecules and means for producing them
08/04/16Antibodies against pd-1 and uses thereof
08/04/16Anti-b7-h1 antibodies for treating tumors
07/21/16Compositions featuring an attenuated newcastle disease virus and methods of use for treating neoplasia
07/07/16Antibody derivatives
07/07/16Binding molecules specific for cd73 and uses thereof
06/30/16Gip and glp-1 receptor dual-agonists for the treatment of diabetes
06/23/16Amino acid derivatives
05/26/16Pyrrolobenzodiazepines and conjugates thereof
05/12/16Targeted pyrrolobenzodiazapine conjugates
05/12/16Therapeutic combinations comprising anti-cd73 antibodies and uses thereof
05/12/16Antibodies to ticagrelor and methods of use
04/21/16Purification of recombinantly produced polypeptides
04/07/16Binding members-513
03/31/16Binding proteins specific for insulin-like growth factors and uses thereof
02/25/16Methods of treatment with antagonists against pd-1 and pd-l1 in combination with radiation therapy
02/04/16Pyrrolobenzodiazepines and conjugates thereof
01/28/16Novel nucleic acid molecules
01/21/16Pegylated glucagon and glp-1 co-agonists for the treatment of obesity
01/07/16Methods of purifying anti-interleukin-13 antibodies
12/31/15Antibody molecule for human gm-csf receptor alpha
11/19/15Myeloma cell culture in transferrin-free low iron medium
10/29/15Glucagon/glp-1 agonists for the treatment of obesity
10/08/15Pyrrolobenzodiazepine - anti-psma antibody conjugates
10/01/15Pyrrolobenzodiazepine-anti-her2 antibody conjugates
09/24/15Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
07/16/15Compounds
06/18/15Antibodies directed to alpha v beta 6 and uses thereof
05/07/15Antibodies directed to angiopoietin-2 and uses thereof
04/16/15Ctla-4 variants
03/19/15Binding members for interleukin-4 receptor alpha (il-4ra) - 173
02/05/15Anti-siglec-15 antibodies and uses thereof
01/22/15Combination therapies using anti-pseudomonas psl and pcrv binding molecules
01/01/15Process for reducing antibody aggregate levels and antibodies produced thereby
12/25/14Rsv-specific binding molecules and means for producing them
10/02/14Methods of obtaining a specific binding member that binds eotaxin
07/31/14Binding members-513
Patent Packs
07/31/14Multiple-variable dose regimen for treating tnfalpha-related disorders
05/08/14Binding members for ige molecules
04/03/14Rsv specific binding molecule
03/20/14Antibody molecule for human gm-csf receptor alpha
03/13/14Rsv-specific binding molecules and means for producing them
01/23/14Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancer
01/09/14Chinese hamster ovary cell line
01/02/14Anti-il-18 antibodies and their uses
10/24/13Factor ii and fibrinogen for treatment of haemostatic disorders
10/24/13Stabilized angiopoietin-2 antibodies and uses thereof
10/24/13Therapies for improving pulmonary function
08/08/13Antibodies directed to alpha v beta 6 and uses thereof
07/18/13Myeloma cell culture in transferrin-free low iron medium
07/11/13Monomeric polypeptides comprising variant fc regions and methods of use
07/04/13Antibodies directed to angiopoietin-2 and uses thereof
Patent Packs
07/04/13Method and composition for the treatment of diseases caused by or associated with hiv
06/13/13Compositions and methods for treating copd exacerbation
04/11/13Antibodies directed to erbb2
03/28/13Binding members-513
03/14/13Compositions and methods relating to proteins requiring gamma-carboxylation
01/03/13Antibodies to human il-22
11/29/12Compounds
11/15/12Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancer
10/25/12Methods of obtaining a specific binding member that binds eotaxin
10/11/12Method for production of recombinant human thrombin
07/05/12Binding members for interleukin-4 receptor alpha (il-4ra) - 173
05/10/12Targeted binding agents directed to a5beta1 and uses thereof
05/03/12Targeted binding agents directed to upar and uses thereof
03/01/12Human antibody molecules for il-13
09/01/11Binding members for ige molecules
08/18/11Binding proteins specific for insulin-like growth factors and uses thereof
02/24/11Stabilized angiopoietin-2 antibodies and uses thereof
12/16/10Methods for producing members of specific binding pairs
11/18/10Pseudomonas exotoxin a cd4+ t-cell epitopes
09/23/10Rsv-specific binding molecules and means for producing them
09/16/10Targeted binding agents directed to heparanase and uses thereof 463
09/02/10Binding members-513
09/02/10Method of treating a pathological syndrome and a pharmaceutical agent
07/22/10Polypeptide variants
07/22/10Antibodies against human il-22 and uses therefor
04/22/10Antibodies specific for the complex of interleukin-6 and the interleukin-6 receptor
12/03/09Interleukin-21 receptor binding proteins
05/21/09Binding member for gm-csf receptor







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Medimmune Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Medimmune Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';